Abstract
Activation of proto-oncogenes and inactivation of tumor suppressor genes (TSGs) occur during multistage carcinogenesis. Proto-oncogenes are activated by gene amplification, point mutation and chromosomal translocation, while TSGs are inactivated by promoter CpG hypermethylation, point mutation, chromosomal translocation, and deletion. Array CGH combined with mRNA microarray analysis is applied for genome-wide screening of proto-oncogenes as well as TSGs [2]. Microarray analysis for lase-captured microdissection (LCM) sample is applied for screening of novel tumor markers specifically expressed in tumor cells [1]. Because huge amounts of data concerning genome sequences, expression profile, copy-number changes of human chromosomal regions in tumors are available in the post-genomic era, we applied bioinformatics for oncogenomic target identification.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
